JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Liver Volumetry Enhances Prediction of Acute Pancreatitis in Acute Liver Failure: A Nationwide Registry Study

  • 0Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Iwate Medical University, Yahaba, Japan.
Hepatology Research : the Official Journal of the Japan Society of Hepatology +

|

October 9, 2025

|

October 9, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Acute pancreatitis occurs in 13.4% of acute liver failure patients and predicts poor outcomes. Liver volumetry (CTLV/SLV ratio) improves prediction beyond conventional markers like MELD score.

Area Of Science

  • Hepatology
  • Gastroenterology
  • Surgical Oncology

Background

  • Acute pancreatitis is a known complication of acute liver failure (ALF).
  • Predictive factors and incidence of pancreatitis in ALF are not well-defined.
  • Conventional markers have limited ability to predict pancreatic complications in ALF.

Purpose Of The Study

  • Determine the incidence and prognostic impact of acute pancreatitis in ALF patients.
  • Evaluate if liver volumetry enhances prediction of pancreatitis beyond conventional markers.
  • Assess the utility of the computed tomography liver volume to standard liver volume (CTLV/SLV) ratio.

Main Methods

  • Retrospective analysis of 142 ALF patients from a Japanese registry (2011-2021).
  • Exclusion of patients with pre-existing acute pancreatitis.
  • Comparison of predictive models: MELD score alone vs. MELD + CTLV/SLV ratio.

Main Results

  • Acute pancreatitis developed in 13.4% of ALF patients, primarily within 8 weeks.
  • Acute pancreatitis independently predicted poor prognosis (p=0.031).
  • The CTLV/SLV ratio was significantly lower in patients with pancreatitis (0.80 vs. 1.07, p<0.001).
  • The enhanced model (MELD + CTLV/SLV) showed superior discrimination (AUC 0.810) vs. MELD alone (AUC 0.704).

Conclusions

  • Liver volumetry significantly improves prediction of acute pancreatitis in ALF patients.
  • Enhanced risk stratification is possible with the MELD + CTLV/SLV model.
  • This approach may optimize clinical management strategies for ALF patients at risk of pancreatitis.

Keywords:

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test 01:22

157

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...

Acute Pancreatitis I: Introduction 01:27

1.1K

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow 01:26

193

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...

Acute Pancreatitis II: Clinical Manifestations and Management 01:30

693

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...

Chronic Pancreatitis II: Collaborative Care 01:29

282

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Detailed History: Understanding the patient's symptoms is critical. It includes inquiring about abdominal pain, weight loss, and digestive issues, which are common in chronic pancreatitis.
Physical Examination: This might reveal abdominal tenderness, jaundice, and signs of malnutrition,...

Ultrasound II: Endoscopic Ultrasound and FibroScan 01:25

482

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Technological Integration: EUS is a sophisticated integration of optical endoscopy and ultrasonography. The endoscope visualizes the mucosal surface directly, while the ultrasound component penetrates deeper to visualize organs and structures beyond the gastrointestinal wall.
Image Formation: The ultrasound...